Who
Minardo John
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, Ironwood Pharmaceuticals.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $1.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Aug 2021
- Last trade
- 10 Mar 2026
- Last filed
- 12 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Mar 2026filed 12 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —136,612 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —136,612 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $70K19,053 at $3.66 | filing |
| 24 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $70K19,053 at $3.66 | filing |
| 23 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $66K17,439 at $3.81 | filing |
| 23 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $66K17,439 at $3.81 | filing |
| 11 Aug 2025filed 13 Aug 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $6,5137,754 at $0.84 | filing |
| 10 Feb 2025filed 12 Feb 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —122,222 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $69K38,938 at $1.76 | filing |
| 17 Jan 2025filed 22 Jan 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —40,187 at $0.00 | filing |
| 12 Aug 2024filed 14 Aug 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $42K9,910 at $4.27 | filing |
| 20 May 2024filed 22 May 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $112K17,404 at $6.45 | filing |
| 8 Mar 2024filed 12 Mar 2024 | IRWD Ironwood Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —32,752 at $0.00 | filing |
| 8 Mar 2024filed 12 Mar 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —32,752 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | IRWD Ironwood Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —27,214 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $722K47,380 at $15.24 | filing |
| 12 Feb 2024filed 14 Feb 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —54,427 at $0.00 | filing |
| 17 Jan 2024filed 19 Jan 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —79,981 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $71K7,045 at $10.04 | filing |
| 8 Mar 2023filed 10 Mar 2023 | IRWD Ironwood Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —32,751 at $0.00 | filing |
News
Ironwood Pharmaceuticals (NASDAQ:IRWD) and Exicure (NASDAQ:XCUR) Financial ComparisonIRWD · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Minardo John; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.